A Three-Step Taxane Titration Protocol Decreases Hypersensitivity Reactions During First and Second Exposures
暂无分享,去创建一个
[1] L. Gilbert,et al. Premedication Protocols to Prevent Hypersensitivity Reactions to Chemotherapy: a Literature Review , 2022, Clinical Reviews in Allergy & Immunology.
[2] T. Ng,et al. Pre-medication protocols for the prevention of paclitaxel-induced infusion related reactions: a systematic review and meta-analysis , 2022, Supportive Care in Cancer.
[3] Benjamin D. McNeil. MRGPRX2 and Adverse Drug Reactions , 2021, Frontiers in Immunology.
[4] D. Khan,et al. Non-IgE-Mediated Drug Hypersensitivity Reactions , 2021, Current Allergy and Asthma Reports.
[5] P. Bonadonna,et al. Hypersensitivity reactions to chemotherapy: an EAACI Position Paper , 2021, Allergy.
[6] E. Álvarez-Cuesta,et al. Medical algorithm: Diagnosis and treatment of hypersensitivity reactions to cancer chemotherapy , 2021, Allergy.
[7] W. Santimaleeworagun,et al. Characteristics of immediate hypersensitivity reaction to paclitaxel-based chemotherapy in gynecologic cancer patients. , 2020, Asian Pacific journal of allergy and immunology.
[8] J. Herrington,et al. Cetirizine versus diphenhydramine in the prevention of chemotherapy-related hypersensitivity reactions , 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
[9] A. Knezevic,et al. Hypersensitivity Reactions: Priming practice change to reduce incidence in first‐dose rituximab treatment , 2018, Clinical journal of oncology nursing.
[10] Jiju Antony,et al. Six Sigma in healthcare: a systematic review of the literature , 2018 .
[11] M. Picard. Management of Hypersensitivity Reactions to Taxanes. , 2017, Immunology and allergy clinics of North America.
[12] U. Matulonis,et al. Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions. , 2016, The Journal of allergy and clinical immunology.
[13] M. Castells,et al. Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review , 2015, Clinical Reviews in Allergy & Immunology.
[14] G. Wallen. Innovations that INSPIRE. , 2014, Nursing management.
[15] C. Camargo,et al. Management of hypersensitivity reactions to Carboplatin and Paclitaxel in an outpatient oncology infusion center: a 5-year review. , 2014, The journal of allergy and clinical immunology. In practice.
[16] M. P. Berges-Gimeno,et al. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment , 2013, Allergy.
[17] M. Saif,et al. Hypersensitivity Reactions to Docetaxel: Retrospective Evaluation and Development of a Desensitization Protocol , 2010, International Archives of Allergy and Immunology.
[18] U. Matulonis,et al. Food , drug , insect sting allergy , and anaphylaxis Hypersensitivity reactions to chemotherapy : Outcomes and safety of rapid desensitization in 413 cases , 2022 .
[19] S. Brown. Clinical features and severity grading of anaphylaxis. , 2004, The Journal of allergy and clinical immunology.
[20] M. Allwood,et al. The extraction of diethylhexylphthalate (DEHP) from polyvinyl chloride components of intravenous infusion containers and administration sets by paclitaxel injection , 1996 .
[21] E. Eisenhauer,et al. Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] L. Grochow,et al. Phase I trial of taxol in patients with advanced cancer. , 1987, Cancer treatment reports.